Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation

Overview

About this study

The objective of the proposed study is to evaluate the effectiveness and implementation of a culturally adapted, ANAI family-based incentives intervention for smoking cessation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Index Participants will be eligible if they:

Are an ANAI person (based on self-reported race/ethnicity) and reside in Alaska.
Are aged ≥ 21 years (legal smoking age in Alaska).
Self-report smoking in the past 7 days, biochemically verified with breath expired air carbon monoxide (CO) > 4 ppm and saliva cotinine > 30 n/ml (positive Alere iScreen result).
Smoked > 3 cigarettes per day (cpd) over the past 3 months.
If other tobacco or nicotine product used, cigarettes are the main tobacco product used.
Are considering or willing to make a quit attempt.
Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad mini for the study duration.
Nominate one adult family member who will enroll.

Exclusion Criteria:

Used pharmacotherapy or a stop smoking program within the past 3 months.
Another person in the household is enrolled as the index participant.

Family Member Participants, regardless of smoking status or residence with the index participant, will be eligible if they:

Are ≥ 21 years old.
Are defined as family by the index participant.
Own or have access to a mobile phone or tablet with internet and text messaging capabilities or will be loaned an iPad mini for the study duration.
Both men and women and those from non-ANAI racial/ethnic groups.
Family members may only support one index participant to mitigate concern about lack of independence of household or other support networks, and potential for crosstreatment contamination, which could attenuate effects in the RCT.

Alaska Tribal Health System stakeholders:

Input from healthcare providers, cessation specialists, and THO leaders will be gathered to understand potential facilitators and barriers to adoption of the intervention within the ATHS. The ANTHC team will invite individuals to participate through phone and email communications.

Eligibility last updated 1/17/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Christi Patten, Ph.D.	Open for enrollment	Contact information: Antonia Young (833) 602-0222 akfamilystudy@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Christi Patten, Ph.D.

Open for enrollment

Contact information:

Antonia Young

(833) 602-0222

akfamilystudy@mayo.edu

More information

Publications

Alaska Native and American Indian (ANAI) communities in Alaska are disproportionately affected by commercial tobacco use. Financial incentive interventions promote cigarette smoking cessation, but family-level incentives have not been evaluated. We describe the study protocol to adapt and evaluate the effectiveness and implementation of a remotely delivered, family-based financial incentive intervention for cigarette smoking among Alaskan ANAI people. Read More on PubMed

Clinical Trials